Reference number : 276-2006-2007-Q3-00117, amendment number : , agreement type : C, recipient legal name : Novartis Animal Health Canada Inc.|Novartis Animal Health Canada Inc., recipient country : CA, recipient province : PE, recipient city : Victoria|Victoria, recipient postal code : C0A 2G0, program name english : Atlantic Innovation Fund (AIF) - II, program name french : Fonds d'innovation de l'Atlantique (FIA) - II, program purpose english : nan, program purpose french : nan, agreement title english : 189073, agreement title french : 189073, agreement number : 189073, agreement value : 1836921.0, agreement start date : 2006-11-01, agreement end date : 2011-05-15, description english : Platform development & DNA vaccine for Koi Herpes Virus, description french : Développement de plateforme et d'immun. par ADN pour KHV, expected results english : nan, expected results french : nan, additional information english : The assistance type is Conditionally Repayable Contribution., additional information french : Le type d'aide est Contribution à remboursement conditionnel., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique